This is a news story, published by Université de Genève - Université de Genève, that relates primarily to UNIGE news.
For more biology news, you can click here:
more biology newsFor more news from Université de Genève - Université de Genève, you can click here:
more news from Université de Genève - Université de GenèveOtherweb, Inc is a public benefit corporation, dedicated to improving the quality of news people consume. We are non-partisan, junk-free, and ad-free. We use artificial intelligence (AI) to remove junk from your news feed, and allow you to select the best science news, business news, entertainment news, and much more. If you like biology news, you might also like this article about
glioblastoma cells. We are dedicated to bringing you the highest-quality news, junk-free and ad-free, about your favorite topics. Please come every day to read the latest Glioblastoma news, Brain Tumour Immunology news, biology news, and other high-quality news about any topic that interests you. We are working hard to create the best news aggregator on the web, and to put you in control of your news feed - whether you choose to read the latest news through our website, our news app, or our daily newsletter - all free!
human glioblastomaUniversité de Genève - Université de Genève
•
74% Informative
Scientists at UNIGE and HUG have developed CAR-T cells capable of targeting malignant gliomas while preserving healthy tissue.
Glioblastoma is the most common and most aggressive primary brain tumour, with an average survival after diagnosis of less than two years .
VR Score
78
Informative language
81
Neutral language
48
Article tone
formal
Language
English
Language complexity
71
Offensive language
not offensive
Hate speech
not hateful
Attention-grabbing headline
not detected
Known propaganda techniques
not detected
Time-value
long-living
External references
no external sources
Source diversity
no sources
Affiliate links
no affiliate links